Add like
Add dislike
Add to saved papers

Early diagnosis of radio-insensitive human nasopharyngeal carcinoma xenograft models by diffusion kurtosis imaging.

OBJECTIVE: To investigate the feasibility of DKI in early detection of radio-insensitive nasopharyngeal carcinoma (NPC) xenografts in nude mice.

MATERIALS AND METHODS: Seventy-two nude mice were implanted with CNE-1 (low radio-sensitive) and CNE-2 (high radio-sensitive) NPC cell lines, and their respective xenografts were obtained. Then, the NPC-bearing nude mice were exposed to different doses of fraction irradiation, which are divided into non-irradiated group (G0), 10Gy group (G1), 20Gy group (G2), 30Gy group (G3), 3rd (G4) and 5th (G5) days after the entire dose (30y) of irradiation. Subsequently, DKI was performed on each group. Tumor volumes, shrink rates, D and K parameters were measured by two experienced radiologists. Student's t-test and receiver operating characteristic (ROC) curve analysis were conducted in this study.

RESULTS: The differences of volume shrinkage rate between CNE-1 and -2 were observed in G2 (P = 0.032), with the shrink rates of 5.954% and 27.716%, respectively. The D values were reduced at G1 (DG1 , P = 0.001) and then increased gradually after irradiation. The K values were increased at G1 (KG1 , P = 0.001) and then declined sharply in CNE-2 (P < 0.01), but not in CNE-1 xenografts (P > 0.05). The respective AUC values for DG1 and KG1 were 0.875 and 0.917, with 66.7% and 83.3% sensitivity and 100% specificity, at the cutoff values of 1.27 × 10-3  mm2 /s for parameter D and 0.88 for parameter K.

CONCLUSION: DKI can be used for early detection of radio-insensitive NPC xenografts prior to morphological change, where DG1 and KG1 may be the most valuable indicators.

Full text links

We have located links that may give you full text access.
Can't access the paper?
Try logging in through your university/institutional subscription. For a smoother one-click institutional access experience, please use our mobile app.

Related Resources

For the best experience, use the Read mobile app

Mobile app image

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app

All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.

By using this service, you agree to our terms of use and privacy policy.

Your Privacy Choices Toggle icon

You can now claim free CME credits for this literature searchClaim now

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app